BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Breiteneder H, Peng YQ, Agache I, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K, O'Hehir RE, O'Mahony L, Pfaar O, Torres MJ, Wang DY, Zhang L, Akdis CA. Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma. Allergy 2020;75:3039-68. [PMID: 32893900 DOI: 10.1111/all.14582] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 34.5] [Reference Citation Analysis]
Number Citing Articles
1 Benito‐villalvilla C, de la Rocha‐muñoz A, López‐abente J, Eggel A, Bottoli I, Severin T, Woisetschläger M, Palomares O. Ligelizumab impairs IgE ‐binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN ‐α production and FOXP3 + Treg generation. Allergy 2022. [DOI: 10.1111/all.15567] [Reference Citation Analysis]
2 Galiniak S, Podgórski R, Rachel M, Mazur A. Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study. Sci Rep 2022;12:17669. [PMID: 36271282 DOI: 10.1038/s41598-022-21851-8] [Reference Citation Analysis]
3 Fokkens W, Reitsma S. Unified Airway Disease. Otolaryngologic Clinics of North America 2022. [DOI: 10.1016/j.otc.2022.09.001] [Reference Citation Analysis]
4 Aarestrup FM, Taketomi EA, Santos Galvão CE, Gagete E, Nóbrega Machado Arruda AC, Alves GB, Véras de Araújo Gueiros Lira G, Gonçalves MR, Couto Miziara MG, Maranhão Casado SS, Curi SV, Rufino Pereira VA, Sales V, Solé D, de Paula Motta Rubini N, Cavalcanti Sarinho ES. Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology – ASBAI. World Allergy Organization Journal 2022;15:100697. [DOI: 10.1016/j.waojou.2022.100697] [Reference Citation Analysis]
5 Chang Y, Fan T, Huang J. Anemoside B4 protects against IgE-dependent allergic responses by suppressing the PLC/IP3 and JAK/STAT3 pathways. Chem Biol Interact 2022;366:110153. [PMID: 36084722 DOI: 10.1016/j.cbi.2022.110153] [Reference Citation Analysis]
6 Wu J, Yu Y, Yao X, Zhang Q, Zhou Q, Tang W, Huang X, Ye C. Visualizing the knowledge domains and research trends of childhood asthma: A scientometric analysis with CiteSpace. Front Pediatr 2022;10:1019371. [DOI: 10.3389/fped.2022.1019371] [Reference Citation Analysis]
7 Fouka E, Domvri K, Gkakou F, Alevizaki M, Steiropoulos P, Papakosta D, Porpodis K. Recent insights in the role of biomarkers in severe asthma management. Front Med 2022;9. [DOI: 10.3389/fmed.2022.992565] [Reference Citation Analysis]
8 Habib N, Pasha MA, Tang DD. Current Understanding of Asthma Pathogenesis and Biomarkers. Cells 2022;11:2764. [PMID: 36078171 DOI: 10.3390/cells11172764] [Reference Citation Analysis]
9 Panossian A, Efferth T. Network Pharmacology of Adaptogens in the Assessment of Their Pleiotropic Therapeutic Activity. Pharmaceuticals 2022;15:1051. [DOI: 10.3390/ph15091051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ridolo E, Incorvaia C, Pucciarini F, Makri E, Paoletti G, Canonica GW. Current treatment strategies for seasonal allergic rhinitis: where are we heading? Clin Mol Allergy 2022;20:9. [PMID: 35948975 DOI: 10.1186/s12948-022-00176-x] [Reference Citation Analysis]
11 Joshi V, Chhonker YS, Soni D, Cunningham KC, Samuelson DR, Murry DJ. A Selective and Sensitive LC-MS/MS Method for Quantitation of Indole in Mouse Serum and Tissues. Metabolites 2022;12:716. [DOI: 10.3390/metabo12080716] [Reference Citation Analysis]
12 Verhoeven E, Rouadi P, Jaoude EA, Abouzakouk M, Ansotegui I, Al-ahmad M, Al-nesf MA, Azar C, Bahna S, Cuervo-pardo L, Diamant Z, Douagui H, Maximiliano Gómez R, Díaz SG, Han JK, Idriss S, Irani C, Karam M, Klimek L, Nsouli T, Scadding G, Senior B, Smith P, Yáñez A, Zaitoun F, Hellings PW. Digital tools in allergy and respiratory care. World Allergy Organization Journal 2022;15:100661. [DOI: 10.1016/j.waojou.2022.100661] [Reference Citation Analysis]
13 Vaseghi-shanjani M, Snow AL, Margolis DJ, Latrous M, Milner JD, Turvey SE, Biggs CM. Atopy as Immune Dysregulation: Offender Genes and Targets. The Journal of Allergy and Clinical Immunology: In Practice 2022;10:1737-1756. [DOI: 10.1016/j.jaip.2022.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 van Breugel M, Qi C, Xu Z, Pedersen CT, Petoukhov I, Vonk JM, Gehring U, Berg M, Bügel M, Capraij OA, Forno E, Morin A, Eliasen AU, Jiang Y, van den Berge M, Nawijn MC, Li Y, Chen W, Bont L, Bønnelykke K, Celedón JC, Koppelman GH, Xu C. Nasal DNA methylation at three CpG sites predicts childhood allergic disease.. [DOI: 10.1101/2022.06.17.22276520] [Reference Citation Analysis]
15 López-sanz C, Jiménez-saiz R, Esteban V, Delgado-dolset MI, Perales-chorda C, Villaseñor A, Barber D, Escribese MM. Mast Cell Desensitization in Allergen Immunotherapy. Front Allergy 2022;3. [DOI: 10.3389/falgy.2022.898494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Pampura N, Kamaev AV, Lebedenko AA. Asthma biomarkers in children. new opportunities, real practice and frontiers. Med vestn Ûga Ross 2022;13:91-101. [DOI: 10.21886/2219-8075-2022-13-2-91-101] [Reference Citation Analysis]
17 Montero-Vilchez T, Rodriguez-Pozo JA, Diaz-Calvillo P, Salazar-Nievas M, Tercedor-Sanchez J, Molina-Leyva A, Arias-Santiago S. Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study. J Clin Med 2022;11:3341. [PMID: 35743415 DOI: 10.3390/jcm11123341] [Reference Citation Analysis]
18 Madrigal-burgaleta R, Alvarez-cuesta E, Madrigal-burgaleta R, Broyles AD, Cuesta-herranz J, Guzman-melendez MA, Maciag MC, Phillips EJ, Trubiano JA, Wong JT, Ansotegui I, Ali FR, Angel-pereira D, Banerji A, Berges-gimeno MP, Bernal-rubio L, Brockow K, Cardona Villa R, Castells MC, Caubet J, Chang Y, Ensina LF, Chikhladze M, Chiriac AM, Chung W, Ebisawa M, Fernandes B, Garvey LH, Gomez M, Gomez Vera J, Gonzalez Diaz S, Hong DI, Ivancevich JC, Kang H, Khan DA, Kuruvilla M, Larco Sousa JI, Latour-staffeld P, Liu AY, Macy E, Malling HJ, Maspero J, May SM, Mayorga C, Park MA, Peter J, Picard M, Rodriguez-bouza T, Romano A, Tanno LK, Torres MJ, Ureña-tavera A, Valluzzi RL, Volcheck GW, Yamaguchi M. Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement. World Allergy Organization Journal 2022;15:100640. [DOI: 10.1016/j.waojou.2022.100640] [Reference Citation Analysis]
19 Ridolo E, Incorvaia C, Heffler E, Cavaliere C, Paoletti G, Canonica GW. The Present and Future of Allergen Immunotherapy in Personalized Medicine. JPM 2022;12:774. [DOI: 10.3390/jpm12050774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Cheng S, Wen S, Xie S, Zhang C, Zhang H, Gao K, Fan R, Xie Z, Jiang W. Circulating C-X-C Motif Ligand 13 as a Biomarker for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With Chronic Allergic Rhinitis. Front Pediatr 2022;10:872152. [DOI: 10.3389/fped.2022.872152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Mormile I, Granata F, Detoraki A, Pacella D, Della Casa F, De Rosa F, Romano A, de Paulis A, Rossi FW. Predictive Response to Immunotherapy Score: A Useful Tool for Identifying Eligible Patients for Allergen Immunotherapy. Biomedicines 2022;10:971. [DOI: 10.3390/biomedicines10050971] [Reference Citation Analysis]
22 Warner JO, Warner JA. The Foetal Origins of Allergy and Potential Nutritional Interventions to Prevent Disease. Nutrients 2022;14:1590. [DOI: 10.3390/nu14081590] [Reference Citation Analysis]
23 Bordas-Le Floch V, Berjont N, Batard T, Varese N, O'Hehir RE, Canonica WG, van Zelm MC, Mascarell L. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy. Allergy 2022;77:1263-73. [PMID: 34551124 DOI: 10.1111/all.15107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
24 Rodriguez Del Rio P, Liu AH, Borres MP, Södergren E, Iachetti F, Casale TB. Asthma and Allergy: Unravelling a Tangled Relationship with a Focus on New Biomarkers and Treatment. Int J Mol Sci 2022;23:3881. [PMID: 35409241 DOI: 10.3390/ijms23073881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Kato M. Biomarker for bronchial asthma. Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunollogy 2022;36:86-92. [DOI: 10.3388/jspaci.36.86] [Reference Citation Analysis]
26 Ong HH, Andiappan AK, Duan K, Lum J, Liu J, Tan KS, Howland S, Lee B, Ong YK, Thong M, Chow VT, Wang DY. Transcriptomics of rhinovirus persistence reveals sustained expression of RIG-I and interferon-stimulated genes in nasal epithelial cells in vitro. Allergy 2022. [PMID: 35274302 DOI: 10.1111/all.15280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Xie S, Fan R, Tang Q, Cai X, Zhang H, Wang F, Xie S, Gao K, Zhang J, Xie Z, Jiang W. Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling. Front Immunol 2021;12:805404. [PMID: 35095890 DOI: 10.3389/fimmu.2021.805404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Sun Y, Liu T, Bai W. MAF bZIP Transcription Factor B (MAFB) Protected Against Ovalbumin-Induced Allergic Rhinitis via the Alleviation of Inflammation by Restoring the T Helper (Th) 1/Th2/Th17 Imbalance and Epithelial Barrier Dysfunction. JAA 2022;Volume 15:267-80. [DOI: 10.2147/jaa.s335560] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Panaitescu C, Haidar L, Buzan MR, Grijincu M, Spanu DE, Cojanu C, Laculiceanu A, Bumbacea R, Agache IO. Precision medicine in the allergy clinic: the application of component resolved diagnosis. Expert Rev Clin Immunol 2022. [PMID: 35078387 DOI: 10.1080/1744666X.2022.2034501] [Reference Citation Analysis]
30 Mullins E, Bresson JL, Dalmay T, Dewhurst IC, Epstein MM, George Firbank L, Guerche P, Hejatko J, Naegeli H, Nogué F, Rostoks N, Sánchez Serrano JJ, Savoini G, Veromann E, Veronesi F, Fernandez Dumont A, Moreno FJ; EFSA Panel on Genetically Modified Organisms (GMO). Scientific Opinion on development needs for the allergenicity and protein safety assessment of food and feed products derived from biotechnology. EFSA J 2022;20:e07044. [PMID: 35106091 DOI: 10.2903/j.efsa.2022.7044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
31 Lauret S, Noel-Savina E, Prévot G, Guibert N, Reber L, Brouquières D, Didier A, Guilleminault L. Are serum immunoglobulin concentrations a predictive biomarker of response to anti-IL5/IL5Rα therapies? Respir Med Res 2022;81:100882. [PMID: 34983012 DOI: 10.1016/j.resmer.2021.100882] [Reference Citation Analysis]
32 Agache I, Akdis CA, Akdis M, Brockow K, Chivato T, Del Giacco S, Eiwegger T, Eyerich K, Giménez-Arnau A, Gutermuth J, Guttman-Yassky E, Maurer M, Ogg G, Ong PY, O'Mahony L, Schwarze J, Warner A, Werfel T, Palomares O, Jutel M. EAACI Biologicals Guidelines-Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old. Allergy 2022;77:17-38. [PMID: 34324716 DOI: 10.1111/all.15030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
33 Smith HE, Sheikh A, O'hehir RE. Allergen-Specific Immunotherapy. Allergy Essentials 2022. [DOI: 10.1016/b978-0-323-80912-2.00006-8] [Reference Citation Analysis]
34 Ogulur I, Pat Y, Ardicli O, Barletta E, Cevhertas L, Fernandez-Santamaria R, Huang M, Bel Imam M, Koch J, Ma S, Maurer DJ, Mitamura Y, Peng Y, Radzikowska U, Rinaldi AO, Rodriguez-Coira J, Satitsuksanoa P, Schneider SR, Wallimann A, Zhakparov D, Ziadlou R, Brüggen MC, van de Veen W, Sokolowska M, Baerenfaller K, Zhang L, Akdis M, Akdis CA. Advances and highlights in biomarkers of allergic diseases. Allergy 2021;76:3659-86. [PMID: 34519063 DOI: 10.1111/all.15089] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 18.0] [Reference Citation Analysis]
35 Shamji MH, Valenta R, Jardetzky T, Verhasselt V, Durham SR, Würtzen PA, van Neerven RJJ. The role of allergen-specific IgE, IgG and IgA in allergic disease. Allergy 2021;76:3627-41. [PMID: 33999439 DOI: 10.1111/all.14908] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 28.0] [Reference Citation Analysis]
36 Majumdar S, Bhattacharjee S, Jana T, Saha S. DAAB-V2: Updated database of allergy and asthma biomarkers. Allergy 2021;76:3829-32. [PMID: 34543446 DOI: 10.1111/all.15100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Owora AH, Tepper RS, Ramsey CD, Chan-Yeung M, Watson WTA, Becker AB. Transitions between alternating childhood allergy sensitization and current asthma states: A retrospective cohort analysis. Pediatr Allergy Immunol 2022;33:e13699. [PMID: 34799887 DOI: 10.1111/pai.13699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Anklam E, Bahl MI, Ball R, Beger RD, Cohen J, Fitzpatrick S, Girard P, Halamoda-Kenzaoui B, Hinton D, Hirose A, Hoeveler A, Honma M, Hugas M, Ishida S, Kass GE, Kojima H, Krefting I, Liachenko S, Liu Y, Masters S, Marx U, McCarthy T, Mercer T, Patri A, Pelaez C, Pirmohamed M, Platz S, Ribeiro AJ, Rodricks JV, Rusyn I, Salek RM, Schoonjans R, Silva P, Svendsen CN, Sumner S, Sung K, Tagle D, Tong L, Tong W, Eijnden-van-Raaij JVD, Vary N, Wang T, Waterton J, Wang M, Wen H, Wishart D, Yuan Y, Slikker W Jr. Emerging technologies and their impact on regulatory science. Exp Biol Med (Maywood) 2021;:15353702211052280. [PMID: 34783606 DOI: 10.1177/15353702211052280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
39 Agache I, Eguiluz-Gracia I, Cojanu C, Laculiceanu A, Del Giacco S, Zemelka-Wiacek M, Kosowska A, Akdis CA, Jutel M. Advances and highlights in asthma in 2021. Allergy 2021;76:3390-407. [PMID: 34392546 DOI: 10.1111/all.15054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]
40 Xu X, Reitsma S, Wang Y, Fokkens WJ. Highlights in the advances of chronic rhinosinusitis. Allergy 2021;76:3349-58. [PMID: 33948955 DOI: 10.1111/all.14892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
41 Hülpüsch C, Weins AB, Traidl-Hoffmann C, Reiger M. A new era of atopic eczema research: Advances and highlights. Allergy 2021;76:3408-21. [PMID: 34407212 DOI: 10.1111/all.15058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
42 Boonpiyathad T, Lao-araya M, Chiewchalermsri C, Sangkanjanavanich S, Morita H. Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy? Front Allergy 2021;2:747323. [DOI: 10.3389/falgy.2021.747323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Üzülmez Ö, Kalic T, Mayr V, Lengger N, Tscheppe A, Radauer C, Hafner C, Hemmer W, Breiteneder H. The Major Peanut Allergen Ara h 2 Produced in Nicotiana benthamiana Contains Hydroxyprolines and Is a Viable Alternative to the E. Coli Product in Allergy Diagnosis. Front Plant Sci 2021;12:723363. [PMID: 34671372 DOI: 10.3389/fpls.2021.723363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Lutkova TS, Karzakova LM, Zhuravleva NV, Andreeva NP, Ukhterova ND, Komelyagina NA, Gavrilova ES, Kudryashov SI. MODERN APPROACHES TO THE DIAGNOSIS AND THERAPY OF ALLERGIC DISEASES. Acta med Eurasica 2021. [DOI: 10.47026/2413-4864-2021-3-60-68] [Reference Citation Analysis]
45 Agache I, Palmer E, Sanver D, Kirtland M, Shamji MH. Molecular allergology approach to allergic asthma. Mol Aspects Med 2021;:101027. [PMID: 34579961 DOI: 10.1016/j.mam.2021.101027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
46 Proper SP, Azouz NP, Mersha TB. Achieving Precision Medicine in Allergic Disease: Progress and Challenges. Front Immunol 2021;12:720746. [PMID: 34484229 DOI: 10.3389/fimmu.2021.720746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
47 Baioumy SA, Elgendy A, Ibrahim SM, Taha SI, Fouad SH. Association between serum zonulin level and severity of house dust mite allergic asthma. Allergy Asthma Clin Immunol 2021;17:86. [PMID: 34465387 DOI: 10.1186/s13223-021-00586-7] [Reference Citation Analysis]
48 Mitamura Y, Ogulur I, Pat Y, Rinaldi AO, Ardicli O, Cevhertas L, Brüggen MC, Traidl-Hoffmann C, Akdis M, Akdis CA. Dysregulation of the epithelial barrier by environmental and other exogenous factors. Contact Dermatitis 2021. [PMID: 34420214 DOI: 10.1111/cod.13959] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
49 Fomina DS, Serdotetskova SA, Chernov AA, Lebedkina MS, Nurtazina AI, Gadzhieva MK, Mukhina OA, Bobrikova EN. Optimization of approaches to the management of adult patients with severe atopic dermatitis: analysis of real clinical practice outcomes. Consilium Medicum 2021;23:654-61. [DOI: 10.26442/20751753.2021.8.201115] [Reference Citation Analysis]
50 Santos A, Pité H, Chaves-Loureiro C, Rocha SM, Taborda-Barata L. Metabolic Phenotypes in Asthmatic Adults: Relationship with Inflammatory and Clinical Phenotypes and Prognostic Implications. Metabolites 2021;11:534. [PMID: 34436475 DOI: 10.3390/metabo11080534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Cho HJ, Ha JG, Lee SN, Kim CH, Wang DY, Yoon JH. Differences and similarities between the upper and lower airway: focusing on innate immunity. Rhinology 2021. [PMID: 34339483 DOI: 10.4193/Rhin21.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Agache I, Song Y, Alonso-Coello P, Vogel Y, Rocha C, Solà I, Santero M, Akdis CA, Akdis M, Canonica GW, Chivato T, Del Giacco S, Eiwegger T, Fokkens W, Georgalas C, Gevaert P, Hopkins C, Klimek L, Lund V, Naclerio R, O'Mahony L, Palkonen S, Pfaar O, Schwarze J, Soyka MB, Wang Y, Zhang L, Canelo-Aybar C, Palomares O, Jutel M. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy 2021;76:2337-53. [PMID: 33683704 DOI: 10.1111/all.14809] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 25.0] [Reference Citation Analysis]
53 Freitas M, Neves MMPS, Nouws HPA, Delerue-Matos C. Electrochemical Immunosensor for the Simultaneous Determination of Two Main Peanut Allergenic Proteins (Ara h 1 and Ara h 6) in Food Matrices. Foods 2021;10:1718. [PMID: 34441496 DOI: 10.3390/foods10081718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
54 Hou T, Tsang MS, Chu IM, Kan LL, Hon KL, Leung TF, Lam CW, Wong CK. Skewed inflammation is associated with aberrant interleukin-37 signaling pathway in atopic dermatitis. Allergy 2021;76:2102-14. [PMID: 33569791 DOI: 10.1111/all.14769] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
55 Pfaar O, Creticos PS, Kleine-Tebbe J, Canonica GW, Palomares O, Schülke S. One Hundred Ten Years of Allergen Immunotherapy: A Broad Look Into the Future. J Allergy Clin Immunol Pract 2021;9:1791-803. [PMID: 33966868 DOI: 10.1016/j.jaip.2020.12.067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
56 Lee E, Hong SJ. The microbiome in atopic patients and potential modifications in the context of the severe acute respiratory syndrome coronavirus 2 pandemic. Curr Opin Allergy Clin Immunol 2021;21:245-51. [PMID: 33769313 DOI: 10.1097/ACI.0000000000000738] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Garn H, Potaczek DP, Pfefferle PI. The Hygiene Hypothesis and New Perspectives-Current Challenges Meeting an Old Postulate. Front Immunol 2021;12:637087. [PMID: 33815389 DOI: 10.3389/fimmu.2021.637087] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
58 Gökkaya M, Traidl-hoffmann C. Pollenallergie: Nasale Biomarker gegen Unterversorgung. Deutsches Ärzteblatt Online 2021. [DOI: 10.3238/perspneumo.2021.02.19.07] [Reference Citation Analysis]
59 Wraith DC, Krishna MT. Peptide allergen-specific immunotherapy for allergic airway diseases-State of the art. Clin Exp Allergy 2021;51:751-69. [PMID: 33529435 DOI: 10.1111/cea.13840] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
60 Rijavec M, Krumpestar T, Škrgat S, Kern I, Korošec P. T2-high Asthma, Classified by Sputum mRNA Expression of IL4, IL5, and IL13, is Characterized by Eosinophilia and Severe Phenotype. Life (Basel) 2021;11:92. [PMID: 33513844 DOI: 10.3390/life11020092] [Reference Citation Analysis]
61 薛 金. Methods and Progress of Allergic Rhinitis and Asthma. ACM 2021;11:3714-3720. [DOI: 10.12677/acm.2021.118545] [Reference Citation Analysis]
62 Colas L, Magnan A. Immunothérapie spécifique d’allergènes et médecine personnalisée : quel état des lieux en 2020 ? Revue Française d'Allergologie 2020;60:8S32-8S36. [DOI: 10.1016/s1877-0320(20)30484-x] [Reference Citation Analysis]
63 Pfaar O. Die Allergen-Immuntherapie – State of the Art 2020. Drug Res (Stuttg) 2020;70:S24-S26. [DOI: 10.1055/a-1119-2783] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]